Show
Sort by
-
Subcutaneous Epcoritamab With R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma, Including Double-Hit/Triple-Hit Lymphoma: Updated Results From EPCORE NHL-2
-
Glofitamab Monotherapy Induces High Complete Response Rates in Patients with Heavily Pretreated Relapsed/ Refractory Mantle Cell Lymphoma
-
- Journal Article
- A1
- open access
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report
-
PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols
-
Characterization of duvelisib in patients with refractory marginal zone lymphoma : data from the phase 2 DYNAMO trial
-
Effect of dose modifications on response to duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the DUO trial
-
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
-
An appeal to medical journal editors : the need for a full description of laboratory methods and specimen handling in clinical study reports
-
Effective use of rituximab for acquired amegakaryocytic thrombocytopenia
-
On the detection of newer Epo forms in serum and urine using isoelectric focusing